Company / CapEx per Share
NovaBay Pharmaceuticals, Inc. CapEx per Share History
FY2015-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest CapEx per Share
$0.00
FY2024
5-year range
$0.00 / $0.06
FY2020-FY2024
Trend
-27.4%
vs FY2023
Sector context
#167 of 190
Health Care
What the data says
NovaBay Pharmaceuticals, Inc.'s capex per share of $0.00 is lower than 88% of companies in the Health Care sector (FY2024). Declined from $0.06 to $0.00 over the past 2 years.
Based on SEC 10-K filings.
0.00 in FY2024 with a 5-year CAGR of +6.9%.
Declined from $0.06 to $0.00 over the past 2 years.
Health Care sector context is included.
CapEx per Share over time
Growth rates
- 3-Year CAGR
- +1.0%
- 5-Year CAGR
- +6.9%
- 10-Year CAGR
- -
Sector benchmark
Bottom 12% in Health CareTop 88% of 190This company $0.00 Sector average $2.49
▼
-100.0% below sector average
Key checks
Key Insights
- In FY2024, capex per share decreased 27.4% year-over-year.
- Ranks #167 out of 190 companies in the Health Care sector.
- Peak capex per share was recorded in FY2015.
- Lowest capex per share in the period was in FY2020.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -5.51 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | CapEx per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.00 | -27.4% |
| FY2023 | $0.00 | -96.9% |
| FY2022 | $0.06 | +4520.7% |
| FY2021 | $0.00 | +60.7% |
| FY2020 | $0.00 | -15.6% |
| FY2019 | $0.00 | -66.0% |
| FY2018 | $0.00 | -83.9% |
| FY2017 | $0.02 | -65.2% |
| FY2016 | $0.05 | -22.9% |
| FY2015 | $0.06 | +3806.9% |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026